Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the nurses' health study

New England Journal of Medicine

Volumn 325, Issue 11, 1991, Pages 756-762

  Stampfer, Meir J ^a,b   Colditz, Graham A ^a,b   Willett, Walter C ^a,b   Manson, Joann E ^a   Rosner, Bernard ^a   Speizer, Frank E ^a   Hennekens, Charles H ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0025940856     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199109123251102     Document Type: Article

References (35)

1. See NAPS document no. 04890 for eight pages of supplementary material
2. Stampfer M.J., Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20:47-63.
3. Stampfer M.J., Willett W.C., Colditz G.A., Rosner R., Speizer F.E., Hennekens C.H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985; 313:1044-1049
4. Wilson P.W.F., Garrison R.J., Castelli W.P. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: the Framingham Study. N Engl J Med 1985; 313:1038-1043
5. Bailar J.C. III. When research results are in conflict. N Engl J Med 1985; 313:1080-1081
6. Colditz G.A., Stampfer M.J., Willett W.C., Rosner B., Speizer F.E., Hennekens C.H. A prospective study of parental history of myocardial infarction and coronary heart disease in women. Am J Epidemiol 1986; 123: 48-58.
7. Willett W.C., Sampson L., Stampfer M.J., et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122:51-65.
8. World Health Organization. IHD registers: report of the fifth working group. Copenhagen, Denmark: World Health Organization, 1971.
9. Walker A.E., Robins M., Wienfeld F.D. The National Survey of Stroke: clinical findings. Stroke 1981; 12:Suppl 1:I-13-I-44.
10. Stampfer M.J., Willett W.C., Speizer F.E., et al. Test of the National Death Index. Am J Epidemiol 1984; 119:837-839
11. Colditz G.A., Stampfer M.J., Willett W.C., et al. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol 1987; 126:319-325
12. Rothman K.J., Boice J.D. Jr. Epidemiologic analysis with a programmable calculator. Washington, D.C.: Public Health Service, 1979. (NIH publication no. 79–1649.)
13. Cox D.R. Regression models and life-tables. J R Stat Soc [B] 1972; 34:187-220.
14. Willett W.C., Stampfer M.J. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986; 124:17-27.
15. Colditz G.A., Martin P., Stampfer M.J., et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study in women. Am J Epidemiol 1986; 123:894-900.
16. Stampfer M.J., Colditz G.A., Willett W.C., Rosner B., Speizer F.E., Hennekens C.H. Coronary heart disease risk factors in women: the Nurses#x0027; Health Study experience. In: Eaker E, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary heart disease in women. New York: Haymarket Doyma, 1987: 112-6.
17. Colditz G.A. The Nurses#x0027; Health Study: findings during 10 years of follow-up of a cohort of U.S. women. Curr Probl Obstet Gynecol Fertil 1990; 13:129-174
18. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316:1105-1110
19. Stampfer M.J., Colditz G.A., Willett W.C. Menopause and heart disease: a review. Ann N Y Acad Sci 1990; 592:193-203.
20. Judd H.L., Davidson B.J., Frumar A.M., Shamonki I.M., Lagasse L.D., Ballon S.C. Serum androgens and estrogens in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 1980; 136:859-871
21. Eaker E.D., Castelli W.P. Coronary heart disease and its risk factors among women in the Framingham Study. In: Eaker E, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary heart disease in women. New York: Haymarket Doyma, 1987: 122-32.
22. Sullivan J.M., Zwagg R.V., Lemp G.F., et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988; 108:358-363
23. Gruchow H.W., Anderson A.J., Barboriak J.J., Sobocinski K.A. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988; 115:954-963
24. McFarland K.F., Boniface M.E., Homung C.A., Earnhardt W., Humphries J.O. Risk factors and noncontraceptive estrogen use in women with and without coronary disease. Am Heart J 1989; 117:1209-1214
25. Bush T.L., Miller V.T. Effects of pharmacologic agents used during menopause: impact on lipids and lipoproteins. In: Mishell D, ed. Menopause: physiology and pharmacology. Chicago: Year Book Medical. 1986: 187-208.
26. Lobo R.A. Estrogen and cardiovascular disease. Ann N Y Acad Sci 1990; 592:286-294
27. Paganini-Hill A., Ross R.K., Henderson B.E. Postmenopausal oestrogen treatment and stroke: a prospective study. BMJ 1988; 297:519-522
28. Boysen G., Nyboe J., Appleyard M., et al. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke 1988; 19:1345-1353
29. Henderson B.E., Paganini-Hill A., Ross R.K. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991; 151:75-78
30. Bush T.L., Barrett-Connor E., Cowan L.D., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987; 75:1102-1109
31. Petitti D.B., Perlman J.A., Sidney S. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol 1987; 70:289-293
32. Henderson B.E., Ross R.K., Paganini-Hill A., Mack T.M. Estrogen use and cardiovascular disease. Am J Obstet Gynecol 1986; 154:1181-1186
33. Hillner B.E., Hollenberg J.P., Pauker S.G. Postmenopausal estrogens in prevention of osteoporosis: benefit virtually without risk if cardiovascular effects are considered. Am J Med 1986; 80:1115-1127
34. Weinstein M.C., Schiff I. Cost-effectiveness of hormone replacement therapy in the menopause. Obstet Gynecol Surv 1983; 38:445-455
35. Colditz G.A., Stampfer M.J., Willett W.C., Hennekens C.H., Rosner B., Speizer F.E. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 1990; 264:2648-2653